{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:03:43Z","timestamp":1793725423886,"version":"4.6.1"},"reference-count":304,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.arr.2025.102775","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:53:08Z","timestamp":1747741988000},"page":"102775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Advances in Alzheimer's therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape"],"prefix":"10.1016","volume":"109","author":[{"given":"Vrashabh V.","family":"Sugandhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dnyandev G.","family":"Gadhave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha R.","family":"Ugale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sopan N.","family":"Nangare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal P.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seeprarani","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amol","family":"Lavate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apeksha T.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3591-2080","authenticated-orcid":false,"given":"Keshav Raj","family":"Paudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2025.102775_bib1","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s10534-023-00525-6","article-title":"Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer\u2019s disease via acetylcholinesterase inhibition and oxidative stress reduction","volume":"36","author":"Abd Elmonem","year":"2023","journal-title":"Biometals"},{"key":"10.1016\/j.arr.2025.102775_bib2","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1021\/acs.accounts.3c00370","article-title":"Metal Binding of Alzheimer\u2019s Amyloid-\u03b2 and Its Effect on Peptide Self-Assembly","volume":"56","author":"Abelein","year":"2023","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.arr.2025.102775_bib3","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.3390\/ijms24087258","article-title":"Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer\u2019s Disease","volume":"24","author":"Afsar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ncl.2023.01.001","article-title":"Sex Differences in Alzheimer\u2019s Disease","volume":"41","author":"Aggarwal","year":"2023","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.arr.2025.102775_bib5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s12668-022-00998-8","article-title":"Future of Alzheimer\u2019s Disease: Nanotechnology-Based Diagnostics and Therapeutic Approach","volume":"12","author":"Agraharam","year":"2022","journal-title":"BioNanoSci"},{"key":"10.1016\/j.arr.2025.102775_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2017.05.019","article-title":"Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer\u2019s disease","volume":"260","author":"Agrawal","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.arr.2025.102775_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105008","article-title":"Biomaterials in treatment of Alzheimer\u2019s disease","volume":"145","author":"Agrawal","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2025.102775_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105008","article-title":"Biomaterials in treatment of Alzheimer\u2019s disease","volume":"145","author":"Agrawal","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2025.102775_bib9","doi-asserted-by":"crossref","first-page":"8605","DOI":"10.1039\/D3TB01023F","article-title":"Anti-inflammatory role of gold nanoparticles in the prevention and treatment of Alzheimer\u2019s disease","volume":"11","author":"Aili","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.arr.2025.102775_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/151979","article-title":"Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?","volume":"2015","author":"Alavi Naini","year":"2015","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.arr.2025.102775_bib11","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.7326\/M21-2603","article-title":"The Problem of Aducanumab for the Treatment of Alzheimer Disease","volume":"174","author":"Alexander","year":"2021","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.arr.2025.102775_bib12","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1039\/C7NR00772H","article-title":"Osmotin-loaded magnetic nanoparticles with electromagnetic guidance for the treatment of Alzheimer\u2019s disease","volume":"9","author":"Amin","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.arr.2025.102775_bib13","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1021\/cn4001582","article-title":"Alzheimer\u2019s disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents","volume":"4","author":"Amiri","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/biomedicines11020335","article-title":"The Future of Precision Medicine in the Cure of Alzheimer\u2019s Disease","volume":"11","author":"Arafah","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.102775_bib15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3945\/an.116.012229","article-title":"Recent Findings in Alzheimer Disease and Nutrition Focusing on Epigenetics","volume":"7","author":"Athanasopoulos","year":"2016","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.arr.2025.102775_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13041-024-01118-1","article-title":"The duality of amyloid-\u03b2: its role in normal and Alzheimer\u2019s disease states","volume":"17","author":"Azargoonjahromi","year":"2024","journal-title":"Mol. Brain"},{"key":"10.1016\/j.arr.2025.102775_bib17","doi-asserted-by":"crossref","first-page":"e2920","DOI":"10.1212\/WNL.0000000000012067","article-title":"Mediterranean Diet, Alzheimer Disease Biomarkers, and Brain Atrophy in Old Age","volume":"96","author":"Ballarini","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2025.102775_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40120-020-00218-z","article-title":"CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer\u2019s Disease-A Narrative Review","volume":"9","author":"Barman","year":"2020","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2025.102775_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2025.102775_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102693","article-title":"Does drug repurposing bridge the gaps in management of Parkinson\u2019s disease? Unravelling the facts and fallacies","volume":"105","author":"Bashir","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102775_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.111812","article-title":"MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid \u03b2eta oligomer induced Alzheimer\u2019s like rat model","volume":"164","author":"Bazrgar","year":"2022","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.arr.2025.102775_bib22","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3233\/ADR-220112","article-title":"Metal Nanoparticles in Alzheimer\u2019s Disease","volume":"7","author":"Behera","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3233\/ADR-220112","article-title":"Metal Nanoparticles in Alzheimer\u2019s Disease","volume":"7","author":"Behera","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3233\/ADR-220112","article-title":"Metal Nanoparticles in Alzheimer\u2019s Disease","volume":"7","author":"Behera","year":"2023","journal-title":"J. Alzheimers Dis. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0891988710383571","article-title":"Genetics of Alzheimer Disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","article-title":"Antisense Oligonucleotide Therapies for Neurodegenerative Diseases","volume":"42","author":"Bennett","year":"2019","journal-title":"Annu Rev. Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: New hope for Alzheimer\u2019s disease therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.arr.2025.102775_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jare.2021.07.001","article-title":"CRISPR\/Cas9 gene editing: New hope for Alzheimer\u2019s disease therapeutics","volume":"40","author":"Bhardwaj","year":"2022","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.arr.2025.102775_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10571-024-01519-9","article-title":"The Role of Inflammatory Cascade and Reactive Astrogliosis in Glial Scar Formation Post-spinal Cord Injury","volume":"44","author":"Bhatt","year":"2024","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1016\/j.arr.2025.102775_bib30","first-page":"47","article-title":"Chronic exposure of homocysteine in mice contributes to dopamine loss by enhancing oxidative stress in nigrostriatum and produces behavioral phenotypes of Parkinson\u2019s disease","volume":"6","author":"Bhattacharjee","year":"2016","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib31","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.3390\/ijms23115968","article-title":"Advantages and Limitations of Animal Schizophrenia Models","volume":"23","author":"Bia\u0142o\u0144","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104707","article-title":"Advances and considerations in AD tau-targeted immunotherapy","volume":"134","author":"Bittar","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.102775_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jnc.15035","article-title":"Presynaptic dysfunction in neurodevelopmental disorders: Insights from the synaptic vesicle life cycle","volume":"157","author":"Bonnycastle","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2025.102775_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-180482","article-title":"Next Generation Sequencing Analysis in Early Onset Dementia Patients","volume":"67","author":"Bonvicini","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.102775_bib35","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s42452-024-05811-7","article-title":"Some promising medicinal plants used in Alzheimer\u2019s disease: an ethnopharmacological perspective","volume":"6","author":"Bordoloi","year":"2024","journal-title":"Discov. Appl. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib36","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1007\/s10072-022-06068-x","article-title":"Anxiety and depression in Alzheimer\u2019s disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline","volume":"43","author":"Botto","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib37","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2174\/156720511796717195","article-title":"Tau as a Therapeutic Target for Alzheimer\u2019s Disease","volume":"8","author":"Boutajangout","year":"2011","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2025.102775_bib38","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","article-title":"Accelerating Alzheimer\u2019s therapeutic development: The past and future of clinical trials","volume":"186","author":"Boxer","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.arr.2025.102775_bib39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00213-023-06362-2","article-title":"Evidence of trospium\u2019s ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results","volume":"240","author":"Breier","year":"2023","journal-title":"Psychopharmacol. (Berl. )"},{"key":"10.1016\/j.arr.2025.102775_bib40","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3390\/molecules25245789","article-title":"Comprehensive Review on Alzheimer\u2019s Disease: Causes and Treatment","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.102775_bib41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1185\/030079905X56565","article-title":"Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer\u2019s disease over a 2-year period","volume":"21","author":"Bullock","year":"2005","journal-title":"Curr. Med Res Opin."},{"key":"10.1016\/j.arr.2025.102775_bib42","first-page":"1163","article-title":"Mutations in presenilin 2 and its implications in Alzheimer\u2019s disease and other dementia-associated disorders","author":"Cai","year":"2015","journal-title":"Clin. Interv. Aging 10"},{"key":"10.1016\/j.arr.2025.102775_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13287-024-03737-w","article-title":"Promoting Alzheimer\u2019s disease research and therapy with stem cell technology","volume":"15","author":"Cao","year":"2024","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.arr.2025.102775_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fneur.2012.00073","article-title":"Behavioral and Psychological Symptoms of Dementia","volume":"3","author":"Cerejeira","year":"2012","journal-title":"Front. Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112924","article-title":"Cell models for Alzheimer\u2019s and Parkinson\u2019s disease: At the interface of biology and drug discovery","volume":"149","author":"Cetin","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2025.102775_bib46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuroscience.2007.01.008","article-title":"Antisense Inhibition at the \u03b2-Secretase-Site of APP Reduces Cerebral Amyloid and AChE Activity in Tg2576","volume":"146","author":"Chauhan","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.arr.2025.102775_bib47","article-title":"Engineered exosomes for cancer theranostics: Next-generation tumor targeting","volume":"85","author":"Chavda","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2025.102775_bib48","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.arr.2025.102775_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202414132","article-title":"Electrochemical Monitoring of Real-Time Vesicle Dynamics Induced by Tau in a Confined Nanopipette","volume":"63","author":"Chen","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.arr.2025.102775_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer\u2019s disease: associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","article-title":"Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies","volume":"108","author":"Chen","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102775_bib52","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/molecules27061816","article-title":"Role of Cholinergic Signaling in Alzheimer\u2019s Disease","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.102775_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fnins.2018.00163","article-title":"The Association of Tau With Mitochondrial Dysfunction in Alzheimer\u2019s Disease","volume":"12","author":"Cheng","year":"2018","journal-title":"Front Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2025.102775_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101720","article-title":"Microglia, neurodegeneration and loss of neuroendocrine control","volume":"184","author":"Chowen","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102775_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116821","article-title":"Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists","volume":"176","author":"Chvojkova","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2025.102775_bib57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1590\/1980-57642020dn14-020001","article-title":"Daily functioning and dementia","volume":"14","author":"Cipriani","year":"2020","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.arr.2025.102775_bib58","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.arr.2025.102775_bib59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase Inhibitors: Pharmacology and Toxicology","volume":"11","author":"\u010colovi\u0107","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2025.102775_bib60","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.parkreldis.2011.06.010","article-title":"Increased levels of total tau protein in the cerebrospinal fluid in Huntington\u2019s disease","volume":"17","author":"Constantinescu","year":"2011","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.arr.2025.102775_bib61","first-page":"705","article-title":"Microglia regulation of synaptic plasticity and learning and memory","volume":"17","author":"Cornell","year":"2021","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2025.102775_bib62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40263-020-00779-5","article-title":"Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview","volume":"35","author":"Correll","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2025.102775_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s43556-022-00090-3","article-title":"Vesicle trafficking and vesicle fusion: mechanisms, biological functions, and their implications for potential disease therapy","volume":"3","author":"Cui","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.arr.2025.102775_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-030-05542-4_2","article-title":"The Role of Biomarkers in Alzheimer\u2019s Disease Drug Development","volume":"1118","author":"Cummings","year":"2019","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.arr.2025.102775_bib65","article-title":"Alzheimer\u2019s disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.arr.2025.102775_bib66","article-title":"Alzheimer\u2019s disease drug development pipeline: 2023","volume":"9","author":"Cummings","year":"2023","journal-title":"Alzheimer\u2019S. Dement.: Transl. Res. Clin. Interv."},{"key":"10.1016\/j.arr.2025.102775_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer\u2019s Disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.arr.2025.102775_bib68","article-title":"Brain incoming call from glia during neuroinflammation: Roles of extracellular vesicles","volume":"201","author":"D\u2019Egidio","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.102775_bib69","article-title":"Oxidative stress and inflammation in the pathogenesis of neurological disorders: Mechanisms and implications","author":"Dash","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.arr.2025.102775_bib70","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jshs.2020.01.004","article-title":"Physical exercise in the prevention and treatment of Alzheimer\u2019s disease","volume":"9","author":"De la Rosa","year":"2020","journal-title":"J. Sport Health Sci."},{"key":"10.1016\/j.arr.2025.102775_bib71","article-title":"Microglia and Astrocytes in Alzheimer\u2019s Disease: Significance and Summary of Recent Advances","author":"Deng","year":"2024","journal-title":"Aging Dis. 15, 1537\u20131564"},{"key":"10.1016\/j.arr.2025.102775_bib72","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102775_bib73","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2174\/1567205013666160401115127","article-title":"Alzheimer\u2019s Disease Genetic Risk Factor APOE-\u03b54 Also Affects Normal Brain Function","volume":"13","author":"DiBattista","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2025.102775_bib74","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4103\/neurol-india.Neurol-India-D-23-00592","article-title":"Research Progress of Novel Inorganic Nanomaterials in the Diagnosis and Treatment of Alzheimer\u2019s Disease","volume":"72","author":"Ding","year":"2024","journal-title":"Neurol. India"},{"key":"10.1016\/j.arr.2025.102775_bib75","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13195-018-0457-9","article-title":"Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a network meta-analysis of 41 randomized controlled trials","volume":"10","author":"Dou","year":"2018","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102775_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s Disease: Experimental Models and Reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2025.102775_bib77","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2174\/1389450120666191031092259","article-title":"Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs","volume":"21","author":"Dubey","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.arr.2025.102775_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/21541248.2021.1885264","article-title":"Rac-maninoff and Rho-vel: The symphony of Rho-GTPase signaling at excitatory synapses","volume":"13","author":"Duman","year":"2022","journal-title":"Small GTPases"},{"key":"10.1016\/j.arr.2025.102775_bib79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13287-017-0567-5","article-title":"Alzheimer\u2019s disease, dementia, and stem cell therapy","volume":"8","author":"Duncan","year":"2017","journal-title":"Stem Cell Res Ther."},{"key":"10.1016\/j.arr.2025.102775_bib80","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2005.08.039","article-title":"Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer\u2019s plaques and tangles","volume":"1060","author":"Eskander","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2025.102775_bib81","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2174\/1570159X15666170720095240","article-title":"Microglia and Astrocytes in Alzheimer\u2019s Disease: Implications for Therapy","volume":"16","author":"Fakhoury","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2025.102775_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111428","article-title":"The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases","volume":"138","author":"Feng","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2025.102775_bib83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.arr.2025.102775_bib84","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s13204-018-0909-3","article-title":"Neutropenia and leukopenia protective intranasal olanzapine-loaded lipid-based nanocarriers engineered for brain delivery","volume":"9","author":"Gadhave","year":"2019","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.arr.2025.102775_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121050","article-title":"Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies","volume":"607","author":"Gadhave","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122372","article-title":"Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: Pharmacological and in vitro cytotoxicity studies","volume":"629","author":"Gadhave","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib87","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pharma.2022.08.010","article-title":"Nose-to-brain delivery of paliperidone palmitate poloxamer-guar gum nanogel: Formulation, optimization and pharmacological studies in rats","volume":"81","author":"Gadhave","year":"2023","journal-title":"Ann. Pharm. Fran\u00e7aises"},{"key":"10.1016\/j.arr.2025.102775_bib88","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/03639045.2019.1576724","article-title":"Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies","volume":"45","author":"Gadhave","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131491","article-title":"Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine \u2013 Development & characterization in physiologically relevant 3D tissue models","volume":"267","author":"Gadhave","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.102775_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102357","article-title":"Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance","volume":"99","author":"Gadhave","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102775_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148674","article-title":"Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis","volume":"1822","author":"Gadhave","year":"2024","journal-title":"Brain Res"},{"key":"10.1016\/j.arr.2025.102775_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148808","article-title":"Corrigendum to \u201cPotential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis\u201d [Brain Res. 1822 (2023) 148674","volume":"1832","author":"Gadhave","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2025.102775_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123566","article-title":"A Nanoemulgel for Nose-to-Brain delivery of Quetiapine \u2013 QbD-Enabled formulation development & in-vitro characterization","volume":"648","author":"Gadhave","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib94","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1039\/D3MA00736G","article-title":"Biomaterial strategies for regulating the neuroinflammatory response","volume":"5","author":"Galindo","year":"2024","journal-title":"Mater. Adv."},{"key":"10.1016\/j.arr.2025.102775_bib95","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2025.102775_bib96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1750-1326-4-13","article-title":"The role of tau in neurodegeneration","volume":"4","author":"Gendron","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102775_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.bionps.2023.100063","article-title":"Biomarkers of Alzheimer\u2019s disease: Past, present and future clinical use","volume":"8","author":"Georgakas","year":"2023","journal-title":"Biomark. Neuropsychiatry"},{"key":"10.1016\/j.arr.2025.102775_bib98","doi-asserted-by":"crossref","first-page":"5","DOI":"10.19080\/JYP.2019.08.555740","article-title":"Yoga as A Complementary Therapeutic Modality for People with Alzheimer\u2019s Disease: A Review","volume":"8","author":"Ghaffari","year":"2019","journal-title":"JYP"},{"key":"10.1016\/j.arr.2025.102775_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137532","article-title":"Alzheimer\u2019s disease: The role of proteins in formation, mechanisms, and new therapeutic approaches","volume":"817","author":"Gholami","year":"2023","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2025.102775_bib100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/jamaneurol.2018.2505","article-title":"Mechanisms of Cell-to-Cell Transmission of Pathological Tau","volume":"76","author":"Gibbons","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib101","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharep.2015.07.006","article-title":"Therapeutic strategies for Alzheimer\u2019s disease in clinical trials","volume":"68","author":"Gody\u0144","year":"2016","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib102","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s13311-022-01201-2","article-title":"Disease-Modifying Therapies for Alzheimer\u2019s Disease: More Questions than Answers","volume":"19","author":"Golde","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2025.102775_bib103","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2147\/ITT.S305420","article-title":"The Role of Complement in Synaptic Pruning and Neurodegeneration","volume":"10","author":"Gomez-Arboledas","year":"2021","journal-title":"Immunotargets Ther."},{"key":"10.1016\/j.arr.2025.102775_bib104","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/acs.bioconjchem.9b00505","article-title":"Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer\u2019s Disease in Mice","volume":"30","author":"Gothwal","year":"2019","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.arr.2025.102775_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103691","article-title":"Antisense oligonucleotides for Alzheimer\u2019s disease therapy: from the mRNA to miRNA paradigm","volume":"74","author":"Grabowska-Pyrzewicz","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.arr.2025.102775_bib106","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.12998\/wjcc.v11.i15.3385","article-title":"Astrocytes in the central nervous system and their functions in health and disease: A review","volume":"11","author":"Gradisnik","year":"2023","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.arr.2025.102775_bib107","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1177\/0733464819880449","article-title":"Integrating Family Caregivers of People With Alzheimer\u2019s Disease and Dementias into Clinical Appointments: Identifying Potential Best Practices","volume":"39","author":"Griffin","year":"2020","journal-title":"J. Appl. Gerontol."},{"key":"10.1016\/j.arr.2025.102775_bib108","first-page":"13","article-title":"Synapse pathology in Alzheimer\u2019s disease","volume":"139","author":"Griffiths","year":"2023","journal-title":"Semin. Cell Dev. Biol., Spec. Issue.: Alzheimer\u2019S. Dis.: Eff. Brain Circuits Synap."},{"key":"10.1016\/j.arr.2025.102775_bib109","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","article-title":"EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3","volume":"49","author":"Guedj","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2025.102775_bib110","doi-asserted-by":"crossref","first-page":"S611","DOI":"10.3233\/JAD-179935","article-title":"Role of Amyloid-\u03b2 and Tau Proteins in Alzheimer\u2019s Disease: Confuting the Amyloid Cascade","volume":"64","author":"Gulisano","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.102775_bib111","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1474-4422(17)30343-5","article-title":"Pathology and hippocampal atrophy in Alzheimer\u2019s disease","volume":"16","author":"Halliday","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib112","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 Pathway in Alzheimer\u2019s Disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2025.102775_bib113","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2025.102775_bib114","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.arr.2025.102775_bib115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.bbadis.2010.05.009","article-title":"Mouse models of neurological disorders\u2014A comparison of heritable and acquired traits","volume":"1802","author":"Harper","year":"2010","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis., Mouse Models Hum. Neurol. Disord."},{"key":"10.1016\/j.arr.2025.102775_bib116","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3390\/molecules27154839","article-title":"Advances on Therapeutic Strategies for Alzheimer\u2019s Disease: From Medicinal Plant to Nanotechnology","volume":"27","author":"Hassan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.arr.2025.102775_bib117","doi-asserted-by":"crossref","first-page":"11791","DOI":"10.3390\/ijms222111791","article-title":"Combination of the Glutaminyl Cyclase Inhibitor PQ912 (Varoglutamstat) and the Murine Monoclonal Antibody PBD-C06 (m6) Shows Additive Effects on Brain A\u03b2 Pathology in Transgenic Mice","volume":"22","author":"Hoffmann","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib118","article-title":"Insight into the genetic etiology of Alzheimer\u2019s disease: A comprehensive review of the role of rare variants","volume":"13","author":"Hoogmartens","year":"2021","journal-title":"Alzheimers Dement (Amst."},{"key":"10.1016\/j.arr.2025.102775_bib119","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00003088-200241030-00006","article-title":"Estimation of the absolute bioavailability of rivastigmine in patients with mild to moderate dementia of the Alzheimer\u2019s type","volume":"41","author":"Hossain","year":"2002","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0091-3057(03)00128-X","article-title":"Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function","volume":"75","author":"Howes","year":"2003","journal-title":"Pharmacol. Biochem. Behav., Plants Cent. Nerv. Syst."},{"key":"10.1016\/j.arr.2025.102775_bib121","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.stemcr.2023.05.018","article-title":"Familial Alzheimer\u2019s disease-associated PSEN1 mutations affect neurodevelopment through increased Notch signaling","volume":"18","author":"Hurley","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.arr.2025.102775_bib122","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bpj.2023.12.018","article-title":"Calcium- and calmodulin-dependent inhibition of NMDA receptor currents","volume":"123","author":"Iacobucci","year":"2024","journal-title":"Biophys. J."},{"key":"10.1016\/j.arr.2025.102775_bib123","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1208\/s12249-020-01652-w","article-title":"Combined Therapy for Alzheimer\u2019s Disease: Tacrine and PAMAM Dendrimers Co-Administration Reduces the Side Effects of the Drug without Modifying its Activity","volume":"21","author":"Igart\u00faa","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.arr.2025.102775_bib124","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer Disease and Related Tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2025.102775_bib125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","article-title":"Dendritic Tau in Alzheimer\u2019s Disease","volume":"99","author":"Ittner","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2025.102775_bib126","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-023-01657-4","article-title":"Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer\u2019s disease","volume":"8","author":"Iyaswamy","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2025.102775_bib127","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.arr.2025.102775_bib128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1049\/nbt2.12127","article-title":"Brain targeting based nanocarriers loaded with resveratrol in Alzheimer\u2019s disease: A review","volume":"17","author":"Jalili","year":"2023","journal-title":"IET Nanobiotechnol"},{"key":"10.1016\/j.arr.2025.102775_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.enbuild.2021.111298","article-title":"Designing the design of experiments (DOE) \u2013 An investigation on the influence of different factorial designs on the characterization of complex systems","volume":"250","author":"Jankovic","year":"2021","journal-title":"Energy Build."},{"key":"10.1016\/j.arr.2025.102775_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1592\/phco.20.1.1.34664","article-title":"Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer\u2019s disease","volume":"20","author":"Jann","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.arr.2025.102775_bib131","first-page":"58","article-title":"Significance of machine learning in healthcare: Features, pillars and applications","volume":"3","author":"Javaid","year":"2022","journal-title":"Int. J. Intell. Netw."},{"key":"10.1016\/j.arr.2025.102775_bib132","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbadis.2016.06.015","article-title":"Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration","volume":"1863","author":"Jha","year":"2017","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis., Oxid. Stress Mitochondrial Qual. Diabetes\/Obes. Crit. Illn. Spectr. Dis."},{"key":"10.1016\/j.arr.2025.102775_bib133","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12906-017-2064-x","article-title":"Acupuncture for patients with mild to moderate Alzheimer\u2019s disease: a randomized controlled trial","volume":"17","author":"Jia","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.arr.2025.102775_bib134","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/cge.13589","article-title":"Application of CRISPR\/Cas9 gene editing technique in the study of cancer treatment","volume":"97","author":"Jiang","year":"2020","journal-title":"Clin. Genet"},{"key":"10.1016\/j.arr.2025.102775_bib135","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00702-014-1358-0","article-title":"Efficacy and safety of galantamine treatment for patients with Alzheimer\u2019s disease: a meta-analysis of randomized controlled trials","volume":"122","author":"Jiang","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2025.102775_bib136","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.3390\/ijms21093272","article-title":"Combination Drug Therapy for the Management of Alzheimer\u2019s Disease","volume":"21","author":"Kabir","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib137","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1073\/pnas.1504081112","article-title":"Tau stabilizes microtubules by binding at the interface between tubulin heterodimers","volume":"112","author":"Kadavath","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2025.102775_bib138","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41398-021-01684-1","article-title":"Switched A\u03b243 generation in familial Alzheimer\u2019s disease with presenilin 1 mutation","volume":"11","author":"Kakuda","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2025.102775_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102775_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102775_bib141","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/CIA.S129145","article-title":"Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson\u2019s disease dementia","volume":"12","author":"Kandiah","year":"2017","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.arr.2025.102775_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104974","article-title":"Exosome-based approaches in the management of Alzheimer\u2019s disease","volume":"144","author":"Kandimalla","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.arr.2025.102775_bib143","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.dadm.2018.06.001","article-title":"Stability of blood-based biomarkers of Alzheimer\u2019s disease over multiple freeze-thaw cycles","volume":"10","author":"Keshavan","year":"2018","journal-title":"Alzheimers Dement (Amst."},{"key":"10.1016\/j.arr.2025.102775_bib144","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/biomedicines10040845","article-title":"Alteration of Neural Pathways and Its Implications in Alzheimer\u2019s Disease","volume":"10","author":"Kim","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2025.102775_bib145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000486546","article-title":"A Systematic Review and Meta-Analysis of the Effectiveness of Acetylcholinesterase Inhibitors and Memantine in Treating the Cognitive Symptoms of Dementia","volume":"45","author":"Knight","year":"2018","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2025.102775_bib146","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/WNN.0b013e318190cf75","article-title":"Clinical trial design issues in mild to moderate Alzheimer disease","volume":"21","author":"Knopman","year":"2008","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib147","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12213","article-title":"Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019","volume":"17","author":"Knopman","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102775_bib148","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/10837450.2019.1659818","article-title":"Efavirenz-loaded intranasal microemulsion for crossing blood-CNS interfaces in neuronal-AIDS: pharmacokinetic and in vivo safety evaluation","volume":"25","author":"Kokare","year":"2020","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.arr.2025.102775_bib149","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer\u2019s disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharm. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nicl.2013.08.007","article-title":"Hippocampal subfield volumetry in mild cognitive impairment, Alzheimer\u2019s disease and semantic dementia","volume":"3","author":"La Joie","year":"2013","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.arr.2025.102775_bib151","article-title":"Biomaterials enhancing performance of cell and nucleic-acid therapies: An opportunity in the brain","volume":"5","author":"Lally","year":"2022","journal-title":"Biomater. Biosyst."},{"key":"10.1016\/j.arr.2025.102775_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002270","article-title":"APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases","volume":"14","author":"Lanoisel\u00e9e","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/j.arr.2025.102775_bib153","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/stem.1125","article-title":"Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid \u03b2 ameliorates Alzheimer\u2019s disease in mice by recruiting bone marrow-induced microglia immune responses","volume":"30","author":"Lee","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.arr.2025.102775_bib154","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.pneurobio.2013.03.001","article-title":"Tau degradation: the ubiquitin-proteasome system versus the autophagy-lysosome system","volume":"105","author":"Lee","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102775_bib155","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73822-6","article-title":"Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning","volume":"10","author":"Lenina","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib156","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/ebmental-2020-300184","article-title":"Linking the Mini-Mental State Examination, the Alzheimer\u2019s Disease Assessment Scale\u2013Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil","volume":"24","author":"Levine","year":"2021","journal-title":"Evid. Based Ment. Health"},{"key":"10.1016\/j.arr.2025.102775_bib157","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fnins.2019.00472","article-title":"Meta-Analysis of Randomized Controlled Trials on the Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer\u2019s Disease","volume":"13","author":"Li","year":"2019","journal-title":"Front Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.937486","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019","volume":"14","author":"Li","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib159","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","article-title":"MicroRNAs: pioneering regulators in Alzheimer\u2019s disease pathogenesis, diagnosis, and therapy","volume":"14","author":"Li","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.arr.2025.102775_bib160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/joim.13244","article-title":"Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer\u2019s disease (MCI and dementia) in primary care: a review and synthesis","volume":"290","author":"Liss","year":"2021","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.arr.2025.102775_bib161","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejphar.2003.11.080","article-title":"Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer\u2019s disease","volume":"486","author":"Liston","year":"2004","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib162","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib163","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnins.2019.00043","article-title":"The Role of NMDA Receptors in Alzheimer\u2019s Disease","volume":"13","author":"Liu","year":"2019","journal-title":"Front Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib164","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.reprotox.2022.04.010","article-title":"DNA methylation in polycystic ovary syndrome: Emerging evidence and challenges","volume":"111","author":"Liu","year":"2022","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.arr.2025.102775_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.135826","article-title":"Present and future use of exosomes containing proteins and RNAs in neurodegenerative diseases for synaptic function regulation: A comprehensive review","volume":"280","author":"Liu","year":"2024","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.102775_bib166","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet (Lond., Engl. )"},{"key":"10.1016\/j.arr.2025.102775_bib167","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2025.102775_bib168","first-page":"15","article-title":"Human disease models in drug development","volume":"1","author":"Loewa","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.arr.2025.102775_bib169","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/s41467-024-46256-1","article-title":"Synapsin 2a tetramerisation selectively controls the presynaptic nanoscale organisation of reserve synaptic vesicles","volume":"15","author":"Longfield","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2025.102775_bib170","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1080\/10717544.2020.1775724","article-title":"Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer\u2019s","volume":"27","author":"Lopez-Barbosa","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.arr.2025.102775_bib171","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s12265-022-10232-1","article-title":"Navigating the Regulatory Pathway for Medical Devices\u2014a Conversation with the FDA, Clinicians, Researchers, and Industry Experts","volume":"15","author":"Lottes","year":"2022","journal-title":"J. Cardiovasc Transl. Res"},{"key":"10.1016\/j.arr.2025.102775_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102578","article-title":"Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer\u2019s disease: A narrative review","volume":"102","author":"Maggiore","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102775_bib173","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s13311-014-0299-5","article-title":"Gene therapy for the nervous system: challenges and new strategies","volume":"11","author":"Maguire","year":"2014","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2025.102775_bib174","article-title":"Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer\u2019s disease","author":"Manczak","year":"2016","journal-title":"Hum. Mol. Genet 25, 5148\u20135166"},{"key":"10.1016\/j.arr.2025.102775_bib175","doi-asserted-by":"crossref","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","article-title":"Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration","volume":"2","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"10.1016\/j.arr.2025.102775_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2025.102775_bib177","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/antiox11050801","article-title":"Mitochondrial Calcium: Effects of Its Imbalance in Disease","volume":"11","author":"Matuz-Mares","year":"2022","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.arr.2025.102775_bib178","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The Role of Tau in Alzheimer\u2019s Disease and Related Disorders","volume":"17","author":"Medeiros","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.arr.2025.102775_bib179","first-page":"34","article-title":"Early-onset Alzheimer Disease and Its Variants","volume":"25","author":"Mendez","year":"2019","journal-title":"Contin. (Minne Minn."},{"key":"10.1016\/j.arr.2025.102775_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1201982","article-title":"Microglia in Alzheimer\u2019s disease: pathogenesis, mechanisms, and therapeutic potentials","volume":"15","author":"Miao","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib181","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neurobiolaging.2024.01.006","article-title":"APOE-\u03b54 is not associated with pure-tone hearing thresholds, visual acuity or cognition, cross-sectionally or over 3 years of follow up in the Canadian Longitudinal Study on Aging","volume":"138","author":"Mick","year":"2024","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2025.102775_bib182","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.3390\/ijms15034671","article-title":"Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction","volume":"15","author":"Mietelska-Porowska","year":"2014","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib183","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/alz.12321","article-title":"Visualization of neurofibrillary tangle maturity in Alzheimer\u2019s disease: A clinicopathologic perspective for biomarker research","volume":"17","author":"Moloney","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102775_bib184","doi-asserted-by":"crossref","DOI":"10.1016\/j.conb.2023.102815","article-title":"Mechanisms of NMDA receptor regulation","volume":"83","author":"Mony","year":"2023","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.arr.2025.102775_bib185","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00401-018-1918-8","article-title":"Questions concerning the role of amyloid-\u03b2 in the definition, aetiology and diagnosis of Alzheimer\u2019s disease","volume":"136","author":"Morris","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2025.102775_bib186","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/ddc2030030","article-title":"Drug Candidates for the Treatment of Alzheimer\u2019s Disease: New Findings from 2021 and 2022","volume":"2","author":"Motebennur","year":"2023","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.arr.2025.102775_bib187","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.21982","article-title":"Association of Mediterranean Diet With Cognitive Decline Among Diverse Hispanic or Latino Adults From the Hispanic Community Health Study\/Study of Latinos","volume":"5","author":"Moustafa","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.arr.2025.102775_bib188","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med"},{"key":"10.1016\/j.arr.2025.102775_bib189","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67460-1","article-title":"Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer\u2019s disease model by increasing the expression of microRNA-146a in hippocampus","volume":"10","author":"Nakano","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41514-024-00136-6","article-title":"Cost of care for Alzheimer\u2019s disease and related dementias in the United States: 2016 to 2060","volume":"10","author":"Nandi","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.arr.2025.102775_bib191","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/10408347.2020.1864716","article-title":"Nanoarchitectured Bioconjugates and Bioreceptors Mediated Surface Plasmon Resonance Biosensor for In Vitro Diagnosis of Alzheimer\u2019s Disease: Development and Future Prospects","volume":"52","author":"Nangare","year":"2022","journal-title":"Crit. Rev. Anal. Chem."},{"key":"10.1016\/j.arr.2025.102775_bib192","first-page":"43","article-title":"Alzheimer\u2019s Disease Puzzle: Delving into Pathogenesis Hypotheses","volume":"15","author":"Nasb","year":"2024","journal-title":"Aging Dis."},{"key":"10.1016\/j.arr.2025.102775_bib193","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/978-3-030-78787-5_48","article-title":"Liposomes: Production Methods and Application in Alzheimer\u2019s Disease","volume":"1339","author":"Naziris","year":"2021","journal-title":"Adv. Exp. Med Biol."},{"key":"10.1016\/j.arr.2025.102775_bib194","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bbadis.2006.12.001","article-title":"Alzheimer disease: Amyloidogenesis, the presenilins and animal models","volume":"1772","author":"Newman","year":"2007","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.arr.2025.102775_bib195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/CS20230513","article-title":"The complement system in neurodegenerative diseases","volume":"138","author":"Nimmo","year":"2024","journal-title":"Clin. Sci. (Lond. )"},{"key":"10.1016\/j.arr.2025.102775_bib196","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/iub.2507","article-title":"Impact of supplementation with vitamins B6, B12, and\/or folic acid on the reduction of homocysteine levels in patients with mild cognitive impairment: A systematic review","volume":"74","author":"Olaso-Gonzalez","year":"2022","journal-title":"IUBMB Life"},{"key":"10.1016\/j.arr.2025.102775_bib197","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-Methyl D-Aspartate (NMDA) Receptor Antagonists and Memantine Treatment for Alzheimer\u2019s Disease, Vascular Dementia and Parkinson\u2019s Disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2025.102775_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165975","article-title":"Donepezil provides neuroprotective effects against brain injury and Alzheimer\u2019s pathology under conditions of cardiac ischemia\/reperfusion injury","volume":"1867","author":"Ongnok","year":"2021","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.arr.2025.102775_bib199","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2147\/ciia.2007.2.1.17","article-title":"Rivastigmine in the treatment of Alzheimer\u2019s disease: an update","volume":"2","author":"Onor","year":"2007","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.arr.2025.102775_bib200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnsyn.2020.00020","article-title":"Nanoliposomes as a Therapeutic Tool for Alzheimer\u2019s Disease","volume":"12","author":"Ord\u00f3\u00f1ez-Guti\u00e9rrez","year":"2020","journal-title":"Front Synaptic Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib201","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/089198879901100401","article-title":"Complementary and Alternative Medicines for Alzheimer\u2019s Disease","volume":"11","author":"Ott","year":"1998","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib202","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1243869","article-title":"Exercise therapy to prevent and treat Alzheimer\u2019s disease","volume":"15","author":"Pahlavani","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-018-1017-7","article-title":"Adaptive designs in clinical trials: why use them, and how to run and report them","volume":"16","author":"Pallmann","year":"2018","journal-title":"BMC Med."},{"key":"10.1016\/j.arr.2025.102775_bib204","article-title":"Graphene quantum dot based ultrasensitive probe for biosensing of prostate cancer biomarkers: current updates and future challenges","volume":"13","author":"Pantwalawalkar","year":"2022","journal-title":"Adv. Nat. Sci: Nanosci. Nanotechnol."},{"key":"10.1016\/j.arr.2025.102775_bib205","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jalz.2009.06.003","article-title":"Alzheimer\u2019s disease drug development and the problem of the blood-brain barrier","volume":"5","author":"Pardridge","year":"2009","journal-title":"Alzheimer\u2019S. Dement.: J. Alzheimer\u2019S. Assoc."},{"key":"10.1016\/j.arr.2025.102775_bib206","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","article-title":"Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse","volume":"53","author":"Parsons","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arr.2025.102775_bib207","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer\u2019s Disease: Treatment Strategies and Their Limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib208","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1206572","article-title":"Current and future therapeutic strategies for Alzheimer\u2019s disease: an overview of drug development bottlenecks","volume":"15","author":"Peng","year":"2023","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib209","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1211\/0022357991772808","article-title":"Medicinal Plants and Alzheimer\u2019s Disease: from Ethnobotany to Phytotherapy","volume":"51","author":"Perry","year":"1999","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.arr.2025.102775_bib210","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3390\/cancers12092574","article-title":"Mitochondrial Metabolism, Contact Sites and Cellular Calcium Signaling: Implications for Tumorigenesis","volume":"12","author":"Peruzzo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arr.2025.102775_bib211","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-021-00783-x","article-title":"Randomized crossover trial of a modified ketogenic diet in Alzheimer\u2019s disease","volume":"13","author":"Phillips","year":"2021","journal-title":"Alzheimer\u2019S. Res. Ther."},{"key":"10.1016\/j.arr.2025.102775_bib212","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1096372","article-title":"Memantine as a neuroprotective agent in ischemic stroke: Preclinical and clinical analysis","volume":"17","author":"Pichardo-Rojas","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib213","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3390\/ijms24010778","article-title":"Apoe4 and Alzheimer\u2019s Disease Pathogenesis\u2014Mitochondrial Deregulation and Targeted Therapeutic Strategies","volume":"24","author":"Pires","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102476","article-title":"Recent advancement in understanding of Alzheimer\u2019s disease: Risk factors, subtypes, and drug targets and potential therapeutics","volume":"101","author":"Prabha","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2025.102775_bib215","series-title":"Alzheimer\u2019s Disease and Advanced Drug Delivery Strategies","first-page":"93","article-title":"Chapter 7 - New biologicals and biomaterials in the therapy of Alzheimer\u2019s disease, in","author":"Prajapati","year":"2024"},{"key":"10.1016\/j.arr.2025.102775_bib216","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176872","article-title":"Emerging paradigms in Alzheimer\u2019s therapy","volume":"981","author":"Preethy H","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2025.102775_bib217","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bcp.2014.01.011","article-title":"Behavioral assays with mouse models of Alzheimer\u2019s disease: practical considerations and guidelines","volume":"88","author":"Puzzo","year":"2014","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib218","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/10717544.2020.1762262","article-title":"Brain delivery of quercetin-loaded exosomes improved cognitive function in AD mice by inhibiting phosphorylated tau-mediated neurofibrillary tangles","volume":"27","author":"Qi","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.arr.2025.102775_bib219","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ibra.12121","article-title":"DNA methylation: The epigenetic mechanism of Alzheimer\u2019s disease","volume":"9","author":"Qin","year":"2023","journal-title":"Ibrain"},{"key":"10.1016\/j.arr.2025.102775_bib220","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s43657-023-00098-x","article-title":"Genetic Phenotypes of Alzheimer\u2019s Disease: Mechanisms and Potential Therapy","volume":"3","author":"Quan","year":"2023","journal-title":"Phenomics"},{"key":"10.1016\/j.arr.2025.102775_bib221","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s11095-023-03506-z","article-title":"Topical Cream Carrying Drug-Loaded Nanogels for Melanoma Treatment","volume":"40","author":"Rahman","year":"2023","journal-title":"Pharm. Res"},{"key":"10.1016\/j.arr.2025.102775_bib222","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer\u2019s disease Neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.102775_bib223","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142981","article-title":"Potential of hyaluronic acid and collagen-based scaffolds in promoting stem cell neuronal differentiation for neuroregenerative therapies: A review","volume":"309","author":"Ranjan","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.102775_bib224","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","article-title":"Hippocampus and its involvement in Alzheimer\u2019s disease: a review","volume":"12","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.arr.2025.102775_bib225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies","volume":"17","author":"Raulin","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2025.102775_bib226","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated Tau in Alzheimer\u2019s Disease and Other Tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.respol.2020.104147","article-title":"Evaluating impact from research: A methodological framework","volume":"50","author":"Reed","year":"2021","journal-title":"Res. Policy"},{"key":"10.1016\/j.arr.2025.102775_bib228","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000512","article-title":"Late-onset vs nonmendelian early-onset Alzheimer disease","volume":"6","author":"Reitz","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.arr.2025.102775_bib229","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jconrel.2021.11.007","article-title":"Block copolymers in Alzheimer\u2019s disease therapy: A perceptive to revolutionize biomaterials","volume":"340","author":"Revdekar","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2025.102775_bib230","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11910-014-0499-8","article-title":"Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies","volume":"14","author":"Ringman","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib231","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01246-y","article-title":"Synaptic tau: A pathological or physiological phenomenon?","volume":"9","author":"Robbins","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2025.102775_bib232","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archinte.158.9.1021","article-title":"Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group","volume":"158","author":"Rogers","year":"1998","journal-title":"Arch. Intern Med"},{"key":"10.1016\/j.arr.2025.102775_bib233","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1021\/acschemneuro.3c00486","article-title":"Oxidative Stress Occurs Prior to Amyloid A\u03b2 Plaque Formation and Tau Phosphorylation in Alzheimer\u2019s Disease: Role of Glutathione and Metal Ions","volume":"14","author":"Roy","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib234","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.3390\/jcm10194582","article-title":"The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer\u2019s Disease","volume":"10","author":"Rujeedawa","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2025.102775_bib235","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.dadm.2017.01.005","article-title":"Pathophysiologic relationship between Alzheimer\u2019s disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis","volume":"7","author":"Santos","year":"2017","journal-title":"Alzheimers Dement (Amst."},{"key":"10.1016\/j.arr.2025.102775_bib236","doi-asserted-by":"crossref","first-page":"193","DOI":"10.14283\/jpad.2022.37","article-title":"Editorial: Aducanumab Trials EMERGE But Don\u2019t ENGAGE","volume":"9","author":"Schneider","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2025.102775_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119129","article-title":"A review on advances of treatment modalities for Alzheimer\u2019s disease","volume":"276","author":"Se Thoe","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2025.102775_bib238","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1016\/j.apsb.2021.11.013","article-title":"Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction","volume":"11","author":"Segovia-Zafra","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.arr.2025.102775_bib239","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.3390\/ijms232112924","article-title":"Amyloid Beta in Aging and Alzheimer\u2019s Disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102270","article-title":"Amyloid \u03b2, Tau, and \u03b1-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","volume":"214","author":"Sengupta","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2025.102775_bib241","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41231-019-0050-7","article-title":"Lost in translation: the valley of death across preclinical and clinical divide \u2013 identification of problems and overcoming obstacles","volume":"4","author":"Seyhan","year":"2019","journal-title":"Transl. Med. Commun."},{"key":"10.1016\/j.arr.2025.102775_bib242","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.pharma.2023.04.003","article-title":"Hepatoprotective activity of Balsamodendron mukul extract against Paracetamol-induced liver toxicity in rats: In vivo pharmacological and toxicological evaluation","volume":"81","author":"Shah","year":"2023","journal-title":"Ann. Pharm. Fran\u00e7aises"},{"key":"10.1016\/j.arr.2025.102775_bib243","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2174\/1570159X18666200128125641","article-title":"Alzheimer\u2019s Disorder: Epigenetic Connection and Associated Risk Factors","volume":"18","author":"Sharma","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.arr.2025.102775_bib244","doi-asserted-by":"crossref","first-page":"53","DOI":"10.5535\/arm.22027","article-title":"Dementia Epidemiology Fact Sheet 2022","volume":"46","author":"Shin","year":"2022","journal-title":"Ann. Rehabil. Med."},{"key":"10.1016\/j.arr.2025.102775_bib245","doi-asserted-by":"crossref","first-page":"6792","DOI":"10.3390\/jcm12216792","article-title":"Anti-Amyloid Therapy, AD, and ARIA: Untangling the Role of CAA","volume":"12","author":"Sin","year":"2023","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.arr.2025.102775_bib246","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","article-title":"Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management","volume":"367","author":"Singh","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.arr.2025.102775_bib247","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.3390\/ijms22179207","article-title":"Tau Protein Interaction Partners and Their Roles in Alzheimer\u2019s Disease and Other Tauopathies","volume":"22","author":"Sinsky","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib248","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1021\/acs.molpharmaceut.4c00708","article-title":"Intracranial Nanogel Pellets Carrying Temozolomide and Paclitaxel for Adjuvant Brain Cancer Therapy","volume":"22","author":"Slika","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib249","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s42826-024-00195-6","article-title":"A review of animal models utilized in preclinical studies of approved gene therapy products: trends and insights","volume":"40","author":"Soufizadeh","year":"2024","journal-title":"Lab Anim. Res"},{"key":"10.1016\/j.arr.2025.102775_bib250","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","article-title":"The evolution of preclinical Alzheimer\u2019s disease: Implications for prevention trials","volume":"84","author":"Sperling","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2025.102775_bib251","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid Related Imaging Abnormalities (ARIA) in Amyloid Modifying Therapeutic Trials: Recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2025.102775_bib252","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrneurol.2012.76","article-title":"Nanotechnology\u2014novel therapeutics for CNS disorders","volume":"8","author":"Srikanth","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib253","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jconrel.2023.12.003","article-title":"MicroRNA-195 liposomes for therapy of Alzheimer\u2019s disease","volume":"365","author":"Su","year":"2024","journal-title":"J. Control Release"},{"key":"10.1016\/j.arr.2025.102775_bib254","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/ijms23010556","article-title":"The Beneficial Effects of Combining Anti-A\u03b2 Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer\u2019s Disease in APP\/PS1 Mice","volume":"23","author":"Su","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib255","article-title":"Development of vitamin B12 containing pullulan-bovine serum albumin microparticles designed dry powder inhaler: In-vitro and in-vivo study","volume":"70","author":"Sugandhi","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2025.102775_bib256","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s Disease: Epidemiology and Clinical Progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.arr.2025.102775_bib257","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e32020","article-title":"Nanotechnology improves the detection of bacteria: Recent advances and future perspectives","volume":"10","author":"Takallu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.arr.2025.102775_bib258","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00228-015-1832-0","article-title":"Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide","volume":"71","author":"Tamargo","year":"2015","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib259","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.7573\/dic.2021-7-3","article-title":"Aducanumab: evidence from clinical trial data and controversies","volume":"10","author":"Tampi","year":"2021","journal-title":"Drugs Context"},{"key":"10.1016\/j.arr.2025.102775_bib260","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ibra.12098","article-title":"Basic information about memantine and its treatment of Alzheimer\u2019s disease and other clinical applications","volume":"9","author":"Tang","year":"2023","journal-title":"Ibrain"},{"key":"10.1016\/j.arr.2025.102775_bib261","doi-asserted-by":"crossref","first-page":"a006148","DOI":"10.1101\/cshperspect.a006148","article-title":"The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment","volume":"2","author":"Tarawneh","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.arr.2025.102775_bib262","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1037\/a0027346","article-title":"Bridging the Gap Between Clinical Research and Clinical Practice: Introduction to the Special Section","volume":"49","author":"Teachman","year":"2012","journal-title":"Psychother. (Chic. )"},{"key":"10.1016\/j.arr.2025.102775_bib263","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3507","article-title":"A comprehensive assessment of the cholinergic-supporting and cognitive-enhancing effects of Rosa damascena Mill. (Damask rose) essential oil on scopolamine-induced amnestic rats","volume":"14","author":"Teral\u0131","year":"2024","journal-title":"Brain Behav."},{"key":"10.1016\/j.arr.2025.102775_bib264","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70018","article-title":"Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review","volume":"5","author":"Thapa","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.arr.2025.102775_bib265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.09.007","article-title":"Probing the correlation of neuronal loss, neurofibrillary tangles and cell death markers across the Alzheimer\u2019s disease\u2019s Braak stages: a quantitative study in humans","volume":"61","author":"Theofilas","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2025.102775_bib266","doi-asserted-by":"crossref","DOI":"10.1038\/srep16117","article-title":"Neurotoxicity induced by zinc oxide nanoparticles: age-related differences and interaction","volume":"5","author":"Tian","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2025.102775_bib267","article-title":"An optimistic approach to nanotechnology in Alzheimer\u2019s disease management: An overview","volume":"86","author":"Tiwari","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2025.102775_bib268","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.3390\/ijms22126355","article-title":"Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer\u2019s Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression","volume":"22","author":"Tolar","year":"2021","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176879","article-title":"Protective effects of L-carnitine against beta-amyloid-induced memory impairment and anxiety-like behavior in a rat model of Alzheimer\u2019s disease","volume":"982","author":"Tork","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.arr.2025.102775_bib270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-642-10324-7_2","article-title":"Species differences in pharmacokinetics and pharmacodynamics","author":"Toutain","year":"2010","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.arr.2025.102775_bib271","first-page":"1","article-title":"Linking environmental risk factors with epigenetic mechanisms in Parkinson\u2019s disease","volume":"9","author":"Tsalenchuk","year":"2023","journal-title":"npj Park. Dis."},{"key":"10.1016\/j.arr.2025.102775_bib272","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.euroneuro.2024.08.511","article-title":"The role of biomarkers in clinical development of drugs for neuropsychiatric disorders - A pragmatic guide","volume":"88","author":"Umbricht","year":"2024","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.arr.2025.102775_bib273","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41684-023-01231-z","article-title":"Animal models to study the neurological manifestations of the post-COVID-19 condition","volume":"52","author":"Usai","year":"2023","journal-title":"Lab Anim. (NY)"},{"key":"10.1016\/j.arr.2025.102775_bib274","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/gim.2015.117","article-title":"The genetic landscape of Alzheimer disease: clinical implications and perspectives","volume":"18","author":"Van Cauwenberghe","year":"2016","journal-title":"Genet. Med."},{"key":"10.1016\/j.arr.2025.102775_bib275","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/CIA.S325026","article-title":"Role of Aducanumab in the Treatment of Alzheimer\u2019s Disease: Challenges and Opportunities","volume":"17","author":"Vaz","year":"2022","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.arr.2025.102775_bib276","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/geriatrics2040034","article-title":"Brain Atrophy Estimated from Structural Magnetic Resonance Imaging as a Marker of Large-Scale Network-Based Neurodegeneration in Aging and Stroke","volume":"2","author":"Veldsman","year":"2017","journal-title":"Geriatrics"},{"key":"10.1016\/j.arr.2025.102775_bib277","article-title":"Translational animal models for Alzheimer\u2019s disease: An Alzheimer\u2019s Association Business Consortium Think Tank","volume":"6","author":"Vitek","year":"2021","journal-title":"Alzheimers Dement (N. Y"},{"key":"10.1016\/j.arr.2025.102775_bib278","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.biopsych.2019.09.019","article-title":"Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies","volume":"87","author":"Vogels","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.arr.2025.102775_bib279","article-title":"Development and characterization of inhaled nintedanib-loaded PLGA nanoparticles using scalable high-pressure homogenization technique","volume":"91","author":"Wang","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.arr.2025.102775_bib280","doi-asserted-by":"crossref","first-page":"15079","DOI":"10.1021\/acs.iecr.9b02196","article-title":"110th Anniversary: Nanoparticle mediated drug delivery for the treatment of Alzheimer\u2019s disease: Crossing the blood-brain barrier","volume":"58","author":"Wechsler","year":"2019","journal-title":"Ind. Eng. Chem. Res"},{"key":"10.1016\/j.arr.2025.102775_bib281","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ijbiomac.2021.03.113","article-title":"The role of amyloid oligomers in neurodegenerative pathologies","volume":"181","author":"Wells","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.arr.2025.102775_bib282","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: Structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.arr.2025.102775_bib283","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","article-title":"The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases","volume":"10","author":"Wu","year":"2021","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2025.102775_bib284","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.695808","article-title":"APP, PSEN1, and PSEN2 Variants in Alzheimer\u2019s Disease: Systematic Re-evaluation According to ACMG Guidelines","volume":"13","author":"Xiao","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib285","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.csbj.2020.08.031","article-title":"CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy","volume":"18","author":"Xu","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.arr.2025.102775_bib286","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s43856-024-00527-6","article-title":"Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer\u2019s disease patients","volume":"4","author":"Yaghmaei","year":"2024","journal-title":"Commun. Med (Lond. )"},{"key":"10.1016\/j.arr.2025.102775_bib287","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40263-016-0361-4","article-title":"Apolipoprotein E as a Therapeutic Target in Alzheimer\u2019s disease: A Review of Basic Research and Clinical Evidence","volume":"30","author":"Yamazaki","year":"2016","journal-title":"CNS Drugs"},{"key":"10.1016\/j.arr.2025.102775_bib288","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2025.102775_bib289","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1021\/cn200028j","article-title":"Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer\u2019s disease in vitro","volume":"2","author":"Yang","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.arr.2025.102775_bib290","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms24043841","article-title":"Neurotransmitters in Prevention and Treatment of Alzheimer\u2019s Disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib291","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.arr.2025.102775_bib292","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.arr.2025.102775_bib293","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.3390\/ijms22158208","article-title":"Novel Therapeutic Approaches for Alzheimer\u2019s Disease: An Updated Review","volume":"22","author":"Yu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib294","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.stemcr.2015.09.010","article-title":"ESC-Derived Basal Forebrain Cholinergic Neurons Ameliorate the Cognitive Symptoms Associated with Alzheimer\u2019s Disease in Mouse Models","volume":"5","author":"Yue","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.arr.2025.102775_bib295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2025.102775_bib296","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.7150\/ijbs.57078","article-title":"Interaction between A\u03b2 and Tau in the Pathogenesis of Alzheimer\u2019s Disease","volume":"17","author":"Zhang","year":"2021","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib297","article-title":"Role of A\u03b2 in Alzheimer\u2019s-related synaptic dysfunction","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.arr.2025.102775_bib298","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13195-024-01384-0","article-title":"Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP\/PS1 Alzheimer\u2019s disease mouse model by regulating the expression of APP secretases","volume":"16","author":"Zhang","year":"2024","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.arr.2025.102775_bib299","article-title":"A meta-analysis of neurogenic exosomes in the diagnosis of Alzheimer\u2019s disease","volume":"9","author":"Zhang","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.arr.2025.102775_bib300","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10072-016-2546-5","article-title":"Dysfunction of NMDA receptors in Alzheimer\u2019s disease","volume":"37","author":"Zhang","year":"2016","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.arr.2025.102775_bib301","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121690","article-title":"Blood-brain barrier Permeable nanoparticles for Alzheimer\u2019s disease treatment by selective mitophagy of microglia","volume":"288","author":"Zhong","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.arr.2025.102775_bib302","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00702-014-1180-8","article-title":"Glutamate as a neurotransmitter in the healthy brain","volume":"121","author":"Zhou","year":"2014","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.arr.2025.102775_bib303","doi-asserted-by":"crossref","DOI":"10.1177\/2516865720910155","article-title":"The Emerging Role of Ten-Eleven Translocation 1 in Epigenetic Responses to Environmental Exposures","volume":"13","author":"Zhu","year":"2020","journal-title":"Epigenet Insights"},{"key":"10.1016\/j.arr.2025.102775_bib304","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.neuroscience.2011.06.088","article-title":"Mesenchymal stem cells rescue the Alzheimer\u2019s disease cell model from cell death induced by misfolded truncated tau","volume":"193","author":"Zilka","year":"2011","journal-title":"Neuroscience"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163725001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T15:12:07Z","timestamp":1753974727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163725001217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":304,"alternative-id":["S1568163725001217"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2025.102775","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Alzheimer's therapy: Exploring neuropathological mechanisms to revolutionize the future therapeutic landscape","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2025.102775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102775"}}